CASE REPORT LEUKEMIA CUTIS- A CASE REPORT

Similar documents
JMSCR Vol 05 Issue 05 Page May 2017

Group of malignant disorders of the hematopoietic tissues characteristically associated with increased numbers of white cells in the bone marrow and

2007 Workshop of Society for Hematopathology & European Association for Hematopathology Indianapolis, IN, USA Case # 228

BLASTIC CRISIS AND MYELOFIBROSIS SIMULTANEOUS COMPLICATIONS IN A CASE OF CHRONIC MYELOCYTIC LEUKEMIA

CHAPTER:4 LEUKEMIA. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY 8/12/2009

Cutaneous Chloroma (Granulocytic Sarcoma)

Bone marrow aspiration as the initial diagnostic tool in the diagnosis of leukemia - A case study

CASE REPORT ATYPICAL BULLOUS PYODERMA GANGRENOSUM WITH EARLY LESIONS MIMICKING CHICKEN POX

Extramedullary precursor T-lymphoblastic transformation of CML at presentation

Pathology. #11 Acute Leukemias. Farah Banyhany. Dr. Sohaib Al- Khatib 23/2/16

Myeloid Sarcoma Presenting as Multiple Lymphadenopathy: A Case Report 1

SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL LEUKEMIA FORMS CHAPTER 16A REVISED: DECEMBER 2017

Juvenile Myelomonocytic Leukemia (JMML)

HAEMATOLOGICAL MALIGNANCY

Differential diagnosis of hematolymphoid tumors composed of medium-sized cells. Brian Skinnider B.C. Cancer Agency, Vancouver General Hospital

Hematology Unit Lab 2 Review Material

Bone Marrow. Procedures Blood Film Aspirate, Cell Block Trephine Biopsy, Touch Imprint

WBCs Disorders 1. Dr. Nabila Hamdi MD, PhD

Classification of Hematologic Malignancies. Patricia Aoun MD MPH

Myeloproliferative Disorders - D Savage - 9 Jan 2002

Hematolymphoid lesions of the skin Part II Myeloid neoplastic proliferations Houston Society of Clinical Pathologists Symposium April 14, 2018

2 nd step do Bone Marrow Study If possible both the aspiration and

Uncommon clinical presentations of leprosy: apropos of three cases

Pathology of Hematopoietic and Lymphoid tissue

Blastic NK-Cell Leukemia / Lymphoma

Done By : WESSEN ADNAN BUTHAINAH AL-MASAEED

MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS LYMPHOMA. April 16, 2008

Heme 9 Myeloid neoplasms

The AML subtypes are based on how mature (developed) the cancer cells are at the time of diagnosis and how different they are from normal cells.

Acute myeloid leukemia. M. Kaźmierczak 2016

Hematopathology Case Study

Myelodysplastic syndrome (MDS) & Myeloproliferative neoplasms

Disclosures. Myeloproliferative Neoplasms: A Case-Based Approach. Objectives. Myeloproliferative Neoplasms. Myeloproliferative Neoplasms

Lymphoma: What You Need to Know. Richard van der Jagt MD, FRCPC

Pathology of Hematopoietic and Lymphoid tissue

HISTOLOGY VIRTUAL LABORATORY BLOOD AND LYMPHATICS SYSTEM

Morfologia normale e patologica

Hematopathology Case Study

Chronic Idiopathic Myelofibrosis (CIMF)

HENATOLYMPHOID SYSTEM THIRD YEAR MEDICAL STUDENTS- UNIVERSITY OF JORDAN AHMAD T. MANSOUR, MD. Part 4 MYELOID NEOPLASMS

9/25/2017. Disclosure. I have nothing to disclose. Young S. Kim MD Dept. of Pathology

Investigation. Li Li 1 Yanan Wang 1 Christine Guo Lian 2 Nina Hu 2 Hongzhong Jin 1 Yuehua Liu 1. DOI:

Notes for the 2 nd histology lab

Myelodysplastic Syndromes: Everyday Challenges and Pitfalls

Title: Erythema annulare centrifugum associated with chronic lymphocytic leukaemia. Authors: Helbling I, Walewska R, Dyer MJS, Bamford M, Harman KE

CASE REPORT CLINICO HEMATOLOGICAL PROFILE OF ACUTE MEGAKARYOBLASTIC LEUKEMIA: REPORT OF FIVE CASES

Myeloid neoplasms. Early arrest in the blast cell or immature cell "we call it acute leukemia" Myoid neoplasm divided in to 3 major categories:

Ordering Physician CLIENT,CLIENT. Collected REVISED REPORT

Cytophagic and S-100 protein immunoreactive myeloid leukemia cutis

Beyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure

Diseases Of The Blood

Peripheral Blood Smear: Diagnostic Clues and Algorithms

ADx Bone Marrow Report. Patient Information Referring Physician Specimen Information

بسم هللا الرحمن الرحيم

Journal of International Academy of Forensic Science & Pathology (JIAFP)

Case Workshop of Society for Hematopathology and European Association for Haematopathology

WHO Classification of Myeloid Neoplasms with Defined Molecular Abnormalities

Utility of FDG PET/CT in the Assessment of Myeloid Sarcoma

WHO Update to Myeloproliferative Neoplasms

Sweet s syndrome: disease spectrum from an Indian perspective

VETERINARY HEMATOLOGY ATLAS OF COMMON DOMESTIC AND NON-DOMESTIC SPECIES COPYRIGHTED MATERIAL SECOND EDITION

1 Introduction. 1.1 Cancer. Introduction

Synonyms. Mast cell disease Mast cell proliferative disease

Diagnostic Approach for Eosinophilia and Mastocytosis. Curtis A. Hanson, M.D.

Lymphomatoid Papulosis 3 Case Reports

Clinicohematological Evaluation of Leukemias in a Tertiary Care Hospital

HEMATOPATHOLOGY (SHANDS HOSPITAL AT THE UNIVERSITY OF FLORIDA): Rotation Director: Ying Li, M.D., Ph.D., Assistant Professor

WBCs Disorders. Dr. Nabila Hamdi MD, PhD

Case Presentation No. 075

Participants Identification No. % Evaluation. Mitotic figure Educational Erythrocyte precursor, abnormal 1 0.

Diagnostic challenge: Acute leukemia with biphenotypic blasts and BCR-ABL1 translocation

Integrated Diagnostic Approach to the Classification of Myeloid Neoplasms. Daniel A. Arber, MD Stanford University

manifestations are uncommon. Initial descriptions of the disease (Rosai and Dorfman, 1969) specifically

الفتوي الاصفر الحبيبوم = Xanthogranuloma_Juvenile JUVENILE XANTHOGRANULOMA 1 / 9

ACUTE LEUKAEMIAS ON BONE MARROW EXAMINATION AND CLINICAL MANIFESTATIONS IN THE TELANGANA POPULATION

ORIGINAL ARTICLE CLINICO PATHOLOGICAL REVIEW OF MEGALOBLASTIC ANAEMIA IN CHILDREN- A 7 YEAR PAEDIATRIC HOSPITAL EXPERIENCE

Mast Cell Disease Case 054 Session 7

Bone Marrow Evaluation of cases of Leukemia in Pathology Department, BJGMC, Pune

Case Report Myeloid Sarcoma Presenting with Leukemoid Reaction in a Child Treated for Acute Lymphoblastic Leukemia

Reactive and Neoplastic Lymphocytosis

Name the condition: Canine sterile neutrophilic dermatosis (Sweet s syndrome)

Management of Extramedullary Leukemia as a Presentation of Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem-Cell Transplantation for Myelodysplastic Syndromes and Myeloproliferative Neoplasms. Policy Specific Section:

MYELODYSPLASTIC SYNDROMES

HEMATOLOGIC MORPHOLOGY- AECOM HEMATOLOGY COURSE

HEAMATOLOGICAL INDICES AND BONE MARROW BIOPSY

Bone Marrow Pathology. Part 1. R.S. Riley, M.D., Ph.D.

HASNA NADIA BT. HASAN SAZALLI JOSEPHIN SUZANA A/K JOHN ASIN LOW NORZUFIKAL BT. ZULKIFLY NURUL ALIYA BT ROSLAN MOHD SYAFFIQ BIN OTHMAN

BSD Self Assessment Workshop 7 th July 2013 CASE 27 RAC6123

Address for correspondence: Dr. PVS Prasad, 88 AUTA Nagar, Sivapuri Post, Annamalai Nagar , Tamil Nadu, India.

FNAC of cutaneous metastatic nodules; a clinicopathologic study with review of literature

HEMATOLOGIC MALIGNANCIES BIOLOGY

Blood Cell Identification Graded

Myeloproliferative Disorders: Diagnostic Enigmas, Therapeutic Dilemmas. James J. Stark, MD, FACP

What is a hematological malignancy? Hematology and Hematologic Malignancies. Etiology of hematological malignancies. Leukemias

Pathology of the Hematopoietic System

BCR-ABL1 positive Myeloid Sarcoma Nicola Austin

Non-Hodgkin lymphomas (NHLs) Hodgkin lymphoma )HL)

Adult Acute leukemia. Matthew Seftel. August

Case Report Ovarian granulocytic sarcoma as the primary manifestation of acute myelogenous leukemia

Transcription:

LEUKEMIA CUTIS- A CASE REPORT C. Nirmala 1, Mangal V. Kulkarni 2. 1. Associate Professor, Department Of Pathology, Bangalore Medical College &RI 2. Tutor, Department Of Pathology, Bangalore Medical College &RI CORRESPONDING AUTHOR: Dr. C. Nirmala, No 85, 17 th main, 15 th cross, Nanjundeshwara layout, J. P. Nagar 5 th phase, Bangalore 560078. E-mail: chandrannirmala@yahoo.com HOW TO CITE THIS ARTICLE: C. Nirmala 1, Mangal V. Kulkarni. Leukemia Cutis - A Case Report. Journal of Evolution of Medical and Dental Sciences 2013; Vol2, Issue 25, June 24; Page: 4531-4535. ABSTRACT: Leukemic cells infiltrating the dermis are referred to as leukemia cutis. Leukemia cutis is seen in myeloid and lymphoid leukemias. Granulocytic sarcoma presenting primarily as skin nodule [leukemia cutis] in CML is a rare entity. Presence of leukemia cutis points towards blast crisis and poorer prognosis even when the hematological parameters point towards a chronic phase. The authors report a case of Leukemia cutis in Chronic Myeloid Leukemia presenting with multiple large skin nodules all over the body. The clinicopathological features of this variant with FNAC cytology, skin biopsy and histopathology findings and peripheral blood smear are discussed with full details. KEY WORDS; CML, Leukemia cutis, Granulocytic sarcoma (GS). INTRODUCTION: Leukemic cells infiltrating the dermis are referred to as leukemia cutis. Leukemia cutis is seen in myeloid and lymphoid leukemias. Leukemia cutis is a rare presentation of Granulocytic sarcoma. Granulocytic sarcoma (chloroma) is formation of localized tumor mass in any part of the body, composed of granulocytic series of cells seen in myeloid leukemias. Granulocytic sarcoma is reported in 3-9% cases of acute and chronic myelogenous leukemia (1). The authors report a case of Leukemia cutis in Chronic Myeloid Leukemia presenting with multiple large skin nodules all over the body. The clinicopathological features of this variant are discussed with full details. CASE REPORT: A 33 yr old male presented with multiple cutaneous nodules over the face, back, anterior chest wall and limbs, associated with fever for duration of 3 months. The patient was referred from the dermatology department with a provisional diagnosis of leishmaniasis for FNAC of the skin nodules. On examination the skin nodules were of varying sizes ranging from 1-5 cms, largest measuring 5x3 cms and average size being 2x1 cms. The nodules were present all over the body, more on face, back, chest wall and limbs. [Fig 1]The nodules were firm to hard and non tender on palpation. FNAC was performed at multiple sites from multiple nodules. Aspiration was Journal of Evolution of Medical and Dental Sciences/ Volume 2/ Issue 25/ June 24, 2013 Page 4531

performed by using 22 g needle and 10 ml disposable syringe. The slides were air dried and wet fixed and stained with Giemsa and H& E. FNAC smears showed presence of myeloid series of cells in varying stages of maturation composed of predominantly myelocytes, metamyelocytes, basophils and eosinophils. Blasts were upto 3% and nucleated RBC s were 3-4%. [fig 2].A diagnosis of granulocytic sarcoma was suspected and subsequent complete haemogram, Bone marrow aspiration and biopsy of the skin nodule was performed. Complete haemogram findings were Hemoglobin - 8.1gm/dl, Total Leucocyte count 3.30lakh/cumm, platelet count is 80,000/cumm, differential leucocyte count blast:3%, promyelocyte:5, myelocytes:24, metamyelocytes:30%, eosinophils:09%, basophils:04%, neutrophils:25%. The above peripheral smear finding is suggestive of chronic myeloid leukemia. Bone marrow study confirmed the feature of chronic myeloid leukemia [Fig 3].A skin biopsy of the nodule was performed. The histopathology showed dermis with a diffuse infiltrate of immature myeloid series of cells composed of myelocytes, metamyelocytes, eosinophils and neutrophils confirming the diagnosis of leukemia cutis [Fig 4&5]. DISCUSSION: Leukemia cutis type of granulocytic sarcoma is a relatively rare condition and may manifest in various types of leukemia. In our present case we see leukemia cutis manifestation in a chronic myeloid leukemia. Leukemia cutis is reported in 2-8% cases of CML (2). Leukemia cutis is a rare presentation of granulocytic sarcoma.granulocytic sarcoma (chloroma) is formation of localized tumor mass in any part of the body, composed of granulocytic series of cells seen in myeloid leukemias. GS is reported in 3-9% cases of acute and chronic myelogenous leukemia. GS was first coined by Rappaport, the other synonyms are chloroma, myeloblastoma, myelocytoma, extra medullary myeloid cell tumor (3). GS is any extra medullary manifestation of acute myeloid leukemia and myeloproliferative diseases, (CML, essential thrombocythemia, polycythemia) myelodysplastic syndrome (1). GS can occur in any organ or tissue. The most common involvement is lymph node, small intestine, mediastinum, CNS, and orbit of eye and bone. (4) The most common involvement includes skull, paranasal sinuses, sternum, ribs, vertebrae and pelvis (3).GS is reported in 3-9% cases of acute and chronic myelogenous leukemia. GS is more common in patients with AML M4 or M5 with Myeloblast which express T cell surface markers CD13 or CD14 and cytogenetic abnormalities of t (8, 21) or inv 16(1). Definitive diagnosis of GS requires a tissue biopsy. A panel of mono clonal antibodies against myeloperoxidase, CD68, CD43 and CD20 helps to accurately diagnose chloroma deposits. Presence of GS gives a poorer prognosis with poorer response to treatment and worse survival (1). GS occurring in a setting of MDS/MPD is equivalent to blast transformation. Incidence of Leukemia cutis is more commonly seen in AML than that of CML. 90% of leukemia cutis may have other extramedullary involvement.(2) Cutaneous lesions in leukemias can be of neoplastic and of paraneoplastic types. Leukemic infiltrates present as variety of skin lesions such as macules, papules, plaques, nodules and ulcers (5). Lesions can be erythematic or purpuric, presence of vesicles and bullae may represent unusual hypersensitivity reaction (2). In the present case the skin nodules were see as large firm nodules ranging from 1-5 cms and the largest nodule measuring 5x3 cms. Cutaneous paraneoplastic diseases are a variety of inflammatory skin conditions that occur in leukemia patients. They include Journal of Evolution of Medical and Dental Sciences/ Volume 2/ Issue 25/ June 24, 2013 Page 4532

erythema nodosum, erythema annulare centrifugum, pyoderma gangrenosum, guttate psoriasis, vitiligo, stasis dermatitis and lesions mimicking urticaria.(2).leukemia cutis should be differentiated from sweet syndrome which is an acute febrile neutrophilic dermatosis found in patients of haematological malignancies (2). On histopathology showed cutaneous leukemic infiltrate with display of several patterns. Most common is the interstitial infiltrate, others are the nodular infiltrate, dense band like infiltrate in the superficial dermis and sparse superficial, deep perivascular and peri adnexal infiltrate are occasional observed (6). The present case showed presence of diffuse leukemic infiltrate in the dermis. A leukemic leukemia cutis is a condition where the extra medullary deposit in the skin occurs in patient with normal peripheral blood or bone marrow. In almost all cases acute leukemia developed shortly afterwards within 1-25 months.(1) Though the skin infiltrate show less than 5% blast and reported in chronic phase of the disease, presence of leukemia cutis strongly suggests that blast crisis is imminent. (7) It is a more aggressive phase of disease (8). 90% of leukemia cutis may have other extramedullary involvement. (2) Histologically granulocytic sarcoma is classified on degree of maturation into three types, 1.Blastic, 2.Immature, 3. Differentiated. Blastic type is composed predominantly of myeloblasts, immature type is composed of myeloblasts and promyelocytes, differentiated type is composed of more promyelocytes and later stages of maturation(8). The present case predominantly mature neutrophils, myelocytes and metamyelocytes, eosinophilic myelocytes, very few blasts and promyelocytes, Hence categorized under differentiated type. Granulocytic sarcoma presenting primarily as skin nodule [leukemia cutis] in CML is a rare entity. Presence of leukemia cutis points towards blast crisis and poorer prognosis even when the hematological parameters point towards a chronic phase. Clinical and morphological identification of GS remains a problem. Only by maintaining a high index of suspicion will clinician and pathologist recognize this tumor in majority of cases. REFERENCES: 1. Wikipedia, myeloid sarcoma. 2. Manish singhal, Sarikal singh, Rajive kumar, Vinod raina. Extensive cutaneous manifestation: presenting feature of chronic myelocytic leukemia in second blast crisis. Indian J of Dermatol 2010; 55(3):265-7. 3. Jitender Mohan kunger, Mukesh Prasad Sharma H Talis. Granulocytic sarcoma of humerus, an unusual association of acute myeloblastic leukemia-a case report. Indian j pathol microbial 2009; (43):475-8. 4. U S Kanade, S D Birare, P Gadgil, SV swami. A case of chronic myelogenous leukemia cutis: a rare presentation. Indian J dermatol.2011; 56:451-2. 5. Yeon soo kang, Hai sung Kim,Hyun Jeong park, Jun young lee et al. Clinical characteristics of 75 patients with leukemia cutis.j Korean med sci 2013;28:614-619 6. Gunnar wagner, Klaus kenchel, Walter back, Alina schulz et al. Leukemia cutisepidemiology, clinical presentation and differential diagnosis. JDDG 2012; 10:27-36 7. Richard.s.neiman, Maurice barcos, costan berard, Hugh bonner et al.granulocytic sarcoma-a clinicopathological study of 61 biopsed cases. Cancer 1981; 48:1426-37. Journal of Evolution of Medical and Dental Sciences/ Volume 2/ Issue 25/ June 24, 2013 Page 4533

8. Elaine S Jaffe, Nancy lee Harris, Harald stein, James W Vardiman. World health organization classification of tumors, pathology and genetics of tumors of hematopoietic and lymphoid tissues. Myeloid sarcoma.2001; 104-5 FIG.1 Multiple skin nodules over face and back Fig 2- FNAC smears showing myeloid series of cells with eosinophilic myelocytes. H&E stain 40X. Journal of Evolution of Medical and Dental Sciences/ Volume 2/ Issue 25/ June 24, 2013 Page 4534

FIG.3 Peripheral smear showing leucocytosis with immature myeloid series of cells composed predominantly of myelocytes, metamyelocytes, and neutrophils. Blasts 1-2% suggesting Chronic Myeloid Leukemia. Leishman s stain, 40 X. FIG 4 Histopathology of skin biopsy, dermis showing diffuse pattern of infiltration by the leukemic cells. H & E, 10x. FIG.5 Histopathology skin biopsy. Dermal infiltrates showing presence of eosinophilic myelocytes and other myeloid series of cells. H & E stain, 40X. Journal of Evolution of Medical and Dental Sciences/ Volume 2/ Issue 25/ June 24, 2013 Page 4535